A Pilot Study for a Randomized Controlled Trial to Compare Trivalent Split Virus Influenza Vaccine to Seasonal Antiviral Prophylaxis in Healthcare and Other Healthy Adults: Assessment of Zanamivir Versus Vaccine (Stop-Flu-2).
Latest Information Update: 13 Jul 2023
At a glance
- Drugs GSK 1536489A (Primary) ; Zanamivir
- Indications Influenza virus infections
- Focus Therapeutic Use
- Acronyms Stop-Flu-2
Most Recent Events
- 01 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Oct 2009 Results have been presented at IDSA 2009.
- 05 Jun 2009 Actual patient number (64) added as reported by ClinicalTrials.gov.